OHSU Knight Cancer Institute Research Groups:OCI Research Group Meetings: Difference between revisions
mNo edit summary |
m (→Schedule) |
||
Line 183: | Line 183: | ||
| <font color=red>3/2/2012</font> | | <font color=red>3/2/2012</font> | ||
| | | | ||
| | | | ||
|Breast Cancer: | |||
| | | | ||
|-- | |-- | ||
Line 274: | Line 273: | ||
|-- | |-- | ||
| <font color=red>6/1/2012</font> | | <font color=red>6/1/2012</font> | ||
| | |Joe Gray | ||
| | |Breast Cancer | ||
|<font color=green> ***Note the location change *** | |<font color=green> ***Note the location change *** | ||
|MAC HALL 2201 | |MAC HALL 2201 |
Revision as of 11:53, 15 February 2012
Home Faculty Graduate Program Postdocs OHSU Knight Core Facilities
Programs
Res Group Meetings
Cancer Journal Club
Cell/CANB 616
Gen. Inst/R3 Club
CANB 610
Objectives of the OHSU Knight Cancer Biology Research Group Meetings
Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:
- Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
- Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics
These meetings are now expanded to include a Translational Cancer Research Group Meeting. The purpose of this meeting is to:
- Serve to foster a Knight translational research incubator for projects and teams leading to multi-investigator cancer program/SPORE funding including the Solid tumors and Hematologic Malignancies programs and the Systems Biology group.
- Meetings will include thematic research and clinical research talks with collaborative and developmental potential and Brainstorming Sessions.
Knight Research Group Activities
Want to join us? All are invited!
- To get on the listserve:
- go to the following web site:
- http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncres
- follow the instructions for subscribing
- We meet in the Knight Conference Room 14th floor Hatfield Research Bldg
- Fridays 9:15-10:15 AM - see schedule below
- Breakfast provided by the Knight!
- Organizer: Rosie Sears, email searsrATohsu.edu
- Translational meeting organizer: Molly Kulesz-Martin, email kuleszma@ohsu.edu
Member Labs and Affiliations
Lopez Lab Hem Onc
Sears Lab, MMG
Hoatlin Lab, BMB
Thayer Lab, BMB
Lloyd Lab, CROET
McCullough Lab, CROET
Wong Lab, Dermatology, CDB
Zundel Lab, Radiation Medicine, Cancer Biology
Spindel Lab, Primate Center, NGP, Cancer Biology
- Add your lab here
Schedule
*Red indicates Translational Cancer Research Group Meetings
Date | Presenters | Topic | Links & Comments | Location |
9/23/2011 | Thomas Jacob | Fluorescent quantum dot nanoparticle technology for molecular assessment of oncogenic kinase signaling | Dr. Tania Vu’s lab in biomedical engineering | |
10/7/2011 | Brett Sheppard | Pancreatic Cancer- Setting the Stage | ||
10/14/2011 | Eliot Spindel | Targeting cholinergic signaling in lung cancer | Dr. Eliot Spindel's lab: Neuroscience meets lung cancer and lung development | |
10/21/2011 | Soren Impey | Pancreas | ||
10/28/2011 | ||||
11/4/2011 | Philip Streeter | Pancreas: Immunoassays for Detection of Early Pancreatic Cancer | ||
11/11/2011 | Joe Gray | Pancreas: “Subtyping pancreatic cancers – advancing diagnosis and treatment” | ||
11/18/2011 | Fox Lab | Pancreas | ||
12/2/2011 | Rosie Sears | Pancreas: | ||
12/9/2011 | Charles Springer | Can MRI Map the Angiogenic Switch in Human Breast Tumors in Vivo? | ||
12/16/2011 | Pancreas: Brain Storming | |||
1/6/2012 | CANCELLED | |||
1/13/2012 |
Steve Chui Shiuh-Wen Luoh |
Breast Cancer: I-Spy-2 and tissue collection | ||
1/20/2012 |
Megan Troxell |
Breast Cancer: Pathologist PI3K mutations in early breast cancer lesions | ||
1/27/2012 | Joshi Alumkal | Thinking Outside the (Androgen) Box in Prostate Cancer | ||
2/3/2012 |
Rosie Sears Jim Korkola |
Breast Cancer: Korkola: Combination Therapies and Irreversible Inhibitors for the treatment of HER2 positive breast cancer; Sears: Strategies to target c-Myc in breast cancer | ||
2/10/2012 | Steven Jacques | Label-free optical imaging of cellular processes | ||
2/17/2012 |
Lisa Coussens |
Breast Cancer: | ||
2/24/2012 | George Thomas | |||
3/2/2012 | Breast Cancer: | |||
3/9/2012 | Daniel Marks | |||
3/16/2012 |
Paul Spellman Xiangshu Xiao |
Breast Cancer: | ||
3/23/2012 | Jen Vomaske | ***Note the location change *** | MAC HALL 3198 | |
3/30/2012 | NO MEETING | Spring Break | ||
4/6/2012 |
John Muschler Sunjong Kwon |
Breast Cancer: | ***Note the location change *** | MAC HALL 2201 |
4/13/2012 | Lucia Carbone, PhD | ***Note the location change *** | MAC HALL 2201 | |
4/20/2012 |
Wassana Yantasee Zhi Hu |
Breast Cancer: | ***Note the location change *** | MAC HALL 2201 |
4/27/2012 | Arthur Edwards | ***Note the location change *** | MAC HALL 2201 | |
5/4/2012 | Juha Rantala
Koei Chin |
Breast Cancer: | ***Note the location change *** | MAC HALL 2201 |
5/11/2012 | Wong Lab (Nick Smith, Emily Bubbers) | ***Note the location change *** | MAC HALL 2201 | |
5/18/2012 | Brainstorming | ***Note the location change *** | MAC HALL 2201 | |
5/25/2012 | Liskay Lab | Modelling Sporadic Intestinal Cancer | ***Note the location change *** | MAC HALL 2201 |
6/1/2012 | Joe Gray | Breast Cancer | ***Note the location change *** | MAC HALL 2201 |
6/8/2012 | Kinrin Yamanaka (Dr. Stephen Lloyd lab) | ***Note the location change *** | MAC HALL 2201 | |
6/22/2012 | Neil Osheroff | ***Note the location change *** | MAC HALL 2201 |